Vantrexa · NSCLC · Spain · Oncology pharmacist · captured by Rachel Adeyemi on 01 May 2026 · reviewed by Dr. Marcus Lindqvist on 04 May 2026
Verbatim as captured; never edited
Oncology pharmacist at Hospital Clínic Barcelona raised elderly / ecog 2 patients during a scientific exchange. They noted that colleagues in their network share the view.
Human-approved by Dr. Marcus Lindqvist on 04 May 2026
Elderly / ECOG 2 patients: interest in collaboration reported by oncology pharmacist (ES).
helixor-private-llm-2026.05 · generated 01 May 2026, 10:00 UTC
AI summary
Elderly / ECOG 2 patients raised by oncology pharmacist; relevant for Medical Communications.
Source spans used by the model
Oncology pharmacist at Hospital Clínic Barcelona raised elderly / ecog 2 patients during a scientific exchange. They noted that colleagues in their network share the view.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Product understanding | Product understanding |
| Function | Medical Communications | Medical Communications |
| Priority | High | High |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 4 | 20% | 16.0 |
| Strategic alignment | 5 | 20% | 20.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 3 | 15% | 9.0 |
| Novelty | 2 | 10% | 4.0 |
| Actionability | 2 | 10% | 4.0 |
| Confidence | 2 | 5% | 2.0 |
| Breadth of occurrence | 3 | 5% | 3.0 |
| Total | High 64 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
30 Apr 2026 · Dr. Valentina Hayashi, Hospital Clínic Barcelona · MSL Rachel Adeyemi
Insight
Reviewed 04 May 2026 by Dr. Marcus Lindqvist
Action
Medical education program · Dr. Sophie Laurent · In progress
Decision
Outcome
Closure
Incorporated into evidence-generation plan.